Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers
Yanyuan Wu(University of California, Los Angeles), Jaydutt V. Vadgama(University of California, Los Angeles)
Cited by 30
Related Papers
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
|International Journal of Oncology|2013|160
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
|Breast Cancer Research and Treatment|2018|114
Proinflammatory Cytokines IL-6 and TNF-<i>α</i>Increased Telomerase Activity through NF-<i>κ</i>B/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells
|Mediators of Inflammation|2017|106